Jeffrey A. Vos

Thromboelastography as a Better Indicator of Hypercoagulable State After Injury Than Prothrombin Time or Activated Partial Thromboplastin Time

Myung S. Park, Wenjun Z. Martini, Michael A. Dubick et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 2009 · 327 citations · Full text

Medicine, Hematology, Hemostasis +13

Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163

Jeffrey A. Vos, Susan L. Abbondanzo, Carol L. Barekman et al. · Modern Pathology · 2005 · 251 citations · Full text

Medicine, Oncology, Pathology +14

The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: A retrospective observational study

Matthew J. Hepburn, Jeffrey A. Vos, Eric P. Fillman et al. · BMC Gastroenterology · 2005 · 88 citations · Full text

Medicine, Infectious Diseases, Pathology +17

Plasmablastic lymphoma versus plasmablastic myeloma: an ongoing diagnostic dilemma

Janice Ahn, Ryan Okal, Jeffrey A. Vos et al. · Journal of Clinical Pathology · 2017 · 70 citations

Medicine, Oncology, Pathology +17

Sibling Donor and Recipient Immune Modulation With Atorvastatin for the Prophylaxis of Acute Graft-Versus-Host Disease

Mehdi Hamadani, Laura F. Gibson, Scot C. Remick et al. · Journal of Clinical Oncology · 2013 · 45 citations · Full text

Life Sciences, Hematology, Immunology +16